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Abstract 
Background:Poly cystic ovary syndrome is one of the most common 
female endocrine disorders. One of the side effects of PCOS is 
oxidative stress.. Here we investigated antioxidants effects of Thymus 
vulgaris ethanoli extract on experimental PCOS induced rats by 
estradiol-valerat (PPA). 
Methods: Wistar female rat (n=70) were divided into 7 groups 
including C1: an equal volume of (0.9% NaCl) as placebo; C2: extract 
(0.6cc/rat/orally/daily); C3: induced PCO by single injection of 
estradiol-valerate (4mg/rat/IM), and T1: PCOS induced  rats+an equal 
volume of (0.9% NaCl) as placebo, T2: PCOS induced rats + 
extract(0.2cc/rat/orally/daily), T3: PCOS induced rats+extract 
(0.4cc/rat/orally/daily), T4:PCOS induced rats+extract 
(0.4cc/rat/orally/daily)test groups, were received extract supplement, 
for 60 consequence days. Animals were kept in standard conditions. In 
last day of study the blood samples of rats in whole groups were 
obtained and prepared to biochemical analysis. 
Results: Total antioxidant capacity level, superoxide dismutase and 
catalase activity were significantly increased in PCOS treated groups 
(P<0.03), these parameters in PCOS groups that did not receive 
extract significantly decreased (P<0.05) in comparison to control. 
Level of MDA in PCOS groups were significantly increased as 
compared to control and extract treated groups (P<0.01). 
Conclusions: Our results showed that administration of Thymus 
vulgaris ethanol extract significantly improved tissue antioxidants level 
in PCOS induced rats. 
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Introduction 
Polycystic ovarian syndrome (PCOS) is one of the most 
common endocrine disorders in reproductive-aged women, 
with prevalence ranging from 5% to 21%.1,2 It is characterized 
by elevated luteinizing hormone, chronic anovulation with 
oligoamenorrhea, enlarged cystic ovaries, obesity, 
hyperandrogenism, and infertility. Insulin resistance is also a 
common feature of the syndrome, which may lead to diabetes 
mellitus type II.3,4 The etiology of PCOS remains unclear and 
is possibly multifactorial. Women with PCOS are at greater 
risk of cardiovascular disease.  
Furthermore, oxidative stress (OS) may play a distinct role 
in the pathophysiology of PCOS.5-8 Reactive oxygen species 
(ROS) are formed in the human body as a result of normal 
cellular function and metabolism. Natural defense mechanisms 
in the form of antioxidants are deployed to modulate ROS. 
Antioxidants are natural substances that suppress or delay OS, 
by scavenging biologically important reactive oxygen species 
(ferryl; O2−; OH−; H2O2; HOCl; alkoxyl, and peroxyl).1,9,10 
Oxidative stress can be generated when there is an imbalance 
between antioxidant defenses and oxidant molecules (reactive 
oxygen and nitrogen species). The role of OS in infertility in 
both males and females has been demonstrated. 
ROS production increases in response to PCOS.6,11 Thus, 
the antioxidant effect is critical to counteract the infertility 
caused by oxidative stress.1 Nowadays, the use of antioxidants 
to manage PCOS is widely established. Several characteristics 
of PCOS, including abdominal adiposity, insulin resistance, 
obesity, and androgen excess, have the potential to enhance 
oxidative stress status in these patients.1 
Phytomedicines have been used for therapeutic purposes 
for centuries.12 Thymus vulgaris L., commonly known as 
thyme, a species of the mint family, Lamiaceae, is native to 
Iran (shirazes, garden, daenensis), and to southern Europe, 
from the western Mediterranean to southern Italy. Growing 
from 15 to 30 cm tall and by 40 cm wide, it is a bushy, woody-
based evergreen subshrub with small, highly aromatic, gray-
green leaves and clusters of purple or pink flowers in early 
summer.13 Thyme is constituted by a number of flavonoids: 
thymol (45.21%), p-cymene (12.90%), γ-terpinene (8.07%), 
carvacrol (5.15%), linalool (3.43%), and (E)-caryophyllene 
(2.45%), which have an antioxidant effect.14 
Numerous studies indicate that thymus petal ethanol extract 
possesses antidepressant, anti-inflammatory, antinociceptive, 
antihypertensive, anti-cancer, and antitumor properties. 
Recently, the antioxidant and antimicrobial properties of thyme 
have been empirically investigated. The beneficial antioxidant 
activity of thyme has been attributed largely to phenolic 
compounds.14-19 
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The aim of this study is to assess the effect of thymus 
vulgaris ethanol extract antioxidants on the total ovary 
antioxidant level in rats with experimentally induced PCOS. 
Materials and Methods 
In this experimental study, 7-week old adult Wistar albino 
female rats (n=70) weighing 250±10 g were obtained from the 
Animal Facility of Pasture Institute, Iran. The animals were 
housed and kept in controlled temperature conditions (25°C) 
and 12 h/12 h light/dark cycle with constant humidity (40–
70%) for 1 week prior to use in experimental procedures. All 
rats were treated in accordance with the principles of 
Laboratory Animal Care [NIH]. All rats were fed a standard 
diet and water. The Wistar female rats were allocated to one of 
the two major groups. The control group (n = 30) was divided 
into subgroups: C1: an equal volume of (0.9% NaCl) as 
placebo; C2: extract (0.6 cc/rat/orally/daily); C3: induced PCO 
by single injection of estradiol-valerate (4 mg/rat/IM), and T1: 
PCOS-induced rats + an equal volume of (0.9% NaCl) as 
placebo, T2: PCOs induced rats+extract (0.2 
cc/rat/orally/daily), T3: PCOS-induced rats+extract (0.4 
cc/rat/orally/daily), T4: PCOS-induced rats+extract (0.4 
cc/rat/orally/daily). All groups were treated for 60 continuous 
days. On the 60th day of the study, 5cc blood samples were 
drawn from rats in all groups and prepared for biochemical 
analysis. Animals were kept in standard conditions.  
The Thymus vulgaris petals were harvested at autumn from 
Gonabad, KhorasanRazavi Provence, and air dried on 
laboratory tables at room temperature (25±2°C) away from 
fluorescent light for three days. They were later ground using a 
crusher. In total, 100 g of each of the ground substances were 
infused separately in double distilled water and 50% ethanol, 
for 72 h with periodic stirring. Each prepared extract was 
filtered repeatedly using a sterile muslin cloth, cotton wool, and 
filter paper. The prepared ethanol extract was freeze dried and 
stored at −80°C.  
For daily using of thymus ethanol extract, a 0.3 mg/ml 
solution was prepared and stoked. The provided supplement 
was administered by the gavage method to the treatment 
groups.  
TAC was measured in serum, using TAC Colorimetric 
Assay Kit (K274-100, Biovision, USA). In this method, Cu2+ 
ion is converted to Cu+ by both small molecule and protein. 
The protein mask prevents Cu2+ reduction by protein, enabling 
the analysis of only the small molecule antioxidants. The 
reduced Cu+ ion is chelated with a colorimetric probe giving a 
broad absorbance peak around 570 nm, proportional to the 
TAC (mmol/L). 
The activity of SOD was measured according to the method 
of Beyer and Fridovich (1987), using the SOD assay kit (cat 
no: 7500-100-K, Funakoshi, Japan)  
GPX was assayed using GPX assay kit (K762-100, 
Biovision, USA). In BioVision’s GPX activity assay, GPX 
reduces cumenehydroperoxide while oxidizing GSH to GSSG. 
The generated GSSG is reduced to GSH with consumption of 
NADPH by GR. The decrease in NADPH (easily measured at 
340 nm) is proportional to GPX activity with a detection 
sensitivity of approximately 0.5 mU/ml of GPX in samples. 
Serum CAT activity was measured using the CAT Activity 
Colorimetric/Fluorometric Assay Kit (k773-100. Biovision, 
USA). In the assay, CAT first reacts with H₂O₂ to produce 
water and oxygen. Unconverted H₂O₂ reacts with OxiRed™ 
probe to produce a product, which can be measured at 570 nm 
(Colorimetric method). 
Tissue MDA levels were determined by the thiobarbituric 
acid method and expressed as nmol MDA formed/mL. Plasma 
MDA concentrations were determined using a 
spectrophotometer. A calibration curve was prepared by using 
1,1′,3,3′-tetramethoxypropane as standard.  
Statistical analysis was performed using the ANOVA and t-
test to comparison data in the control groups with the 
experimental groups using SPSS19 software. The results are 
expressed as mean±SD (standard deviation) and considered 
significant at the level of P<0.05. 
Results  
In PCOS rats, CAT activity indicated a significant decrease 
compared to normal controls (P=0.03). Treatment with thymus 
vulgaris ethanol extract for 60 continuous days significantly 
increased CAT activity in experimental groups, compared with 
control groups, in a dose-dependent manner (P=0.001; Figure 1). 
Treatment with 0.4, 0,6 cc/rat/orally/daily of thyme ethanol 
extract for 60 consecutive days significantly increased 
Superoxide Dismutase (SOD) activity in experimental groups, 
compared with the control 3 and treatment 1 groups (P=0.001). 
Furthermore, PCOS rats showed a significant decrease in SOD 
activity compared to controls (P=0.04, Figure 2).  
As illustrated in Figure 3, administration of thyme ethanol 
extract for 60 consecutive days significantly increased GPX 
activity in experimental groups, compared with the C3 group 
(P=0.001) in a dose-dependent manner (Figure 3). GPX activity 
decreased significantly in PCOS rats compared to control and 
treatment groups (P=0.03). 
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Figure 1. Catalase activity in serum of PCOs induced rats 
As a result of oxidative stress, MDA concentration in PCOS 
rats was significantly elevated (P=0.001). Administration of 
thyme ethanol extract for 60 consecutive days significantly 
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decreased MDA concentration in experimental groups 
compared to control groups (P=0.003, Figure 4).  
As illustrated in Figure 4, administration of thyme ethanol 
extract for 60 consecutive days significantly increased TAC 
concentration in experimental groups compared to control 
groups (C1: P=0.005, C3: P=0.003). In PCOS rats, however, 
TAC decreased significantly (P=0.001, Figure 4). 
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Figure 2. SOD activity in serum of PCOs induced rats 
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Figure 3. GPX activity in serum of PCOs induced rats 
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Figure 4. MDA and TCA concentration in serum of PCOs induced rats 
Discussion 
Oxidative stress is the result of an imbalance between 
production of free radicals that contain unpaired electrons, 
which increase chemical reactivity, and antioxidant defenses 
buffering oxidative damage.6,11It was recently reported that 
MDA levels as an indicator of lipid peroxidation and SOD 
activity increased, and erythrocyte reduced glutathione (GSH) 
levels decreased in women with PCOS.5,20 These observations 
suggest increased oxidant stress and decreased antioxidant 
levels in PCOS.6 
In the female reproductive tissue, elevated ROS levels are 
pursued by active steroidogenesis and metabolism.21-23This 
may cause oocyte and DNA damage. In addition, ROS may 
play a role in the irregular growth of ovarian mesenchyme. In a 
pathological condition such as PCOS, excessive oxidative 
stress might contribute to ovarian mesenchyme hyperplasia. 
During the previous decade, several studies have reported that 
there is an increase in coronary heart disease risk factors in 
women with PCOS.24 Some studies point to a relationship 
between hyperinsulinemia, which is a consequence of insulin 
resistance, and increased risk of cardiovascular disease in 
PCOS.25 ROS causes lipid peroxidation, potentially damaging 
DNA and/or altering cell signaling and cellular function. OS 
can damage the DNA of the ovarian epithelium or cause cell 
apoptosis. However, oxidative status in the cell modulates 
follicular growth, corpus luteum formation, endometrial 
differentiation, and embryonic growth. Oxidative stress might 
also cause preeclampsia, miscarriage, endometriosis, infertility, 
mole hidateform, and free radical-induced birth defects; hence, 
evaluating and protecting against OS is critical in reproductive 
science.26,27 It is necessary to reduce ROS using antioxidant 
agents.   
Enzymatic antioxidant defense systems include GPX, SOD, 
and CAT. Non-enzymatic antioxidants include ascorbic acid 
(Vitamin C), α-tocopherol (Vitamin E), carotenoids, 
ﬂavonoids, glutathione (GSH), and other antioxidants. In a cell, 
there is typically a balance between the activities and levels of 
these antioxidants that is vital for the health of the organism. 
SOD generated in cumulus oophorus cells is closely related to 
oocyte maturation and GPX and CAT are critical for 
reproductive functions; GSH as a redox system is usually found 
in large amounts in the oocytes.1 Despite oxidative stress 
having many physiological roles, increased production of these 
agents might increase the risk of ovarian pathology, which 
might be intensified under conditions of reduced antioxidant 
status.1 
Plants are always suggested as rich sources of antioxidant 
compounds, including a wide variety of active phytochemicals, 
such as flavonoids, terpenoids, sulfides, coumarins, 
polyphenolics, lignans, carotenoids, saponins, curcumins, plant 
sterols, and phthalides.28,29 
A wealth of research on the medicinal characteristics of 
thyme indicates that thyme has a potent antioxidant activity, 
attributed to the presence of thymol as major compound in its 
extract.14,30-35 
In the current study, crude extract was used. This contains 
all components, as well as thymol, p-cymene, γ-terpinene, 
carvacrol, linalool, and (E)-caryophyllene. The results indicate 
a significant difference in oxidative stress in PCOS rats 
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compared to control and thyme treated rats. According to 
previous studies, MDA concentration in PCOS rats is 
significantly elevated as a result of oxidative stress. In this 
group, SOD, GPX, TAC, and CAT showed significant 
reductions in activity or concentration, which may cause 
oxidative damage.7,24,36-38 
Our results showed that thyme extract in non-PCOS rats 
was unable to increase antioxidant defense systems. However, 
PCOS rats treated with thyme ethanol extract had significantly 
decreased concentrations of MDA owing to the antioxidant 
effect of thyme ethanol extract. This was confirmed by elevated 
CAT, SOD, and GPX activity, and increased TAC 
concentration.  
The results indicate that, after treating with thyme ethanol 
extract in the rats with induced PCOS, antioxidant levels (CAT, 
SOD, GPX, and TAC) increased in this group, whilst these 
antioxidants were low in the rats that did not receive thyme. 
MDA as an oxidative species was also decreased in the PCOS 
(treatment) group. Based on the findings of this and previous 
studies, PUFAS is important as an antioxidant to improve and 
modulate PCOS outcome. 
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